High Risk for Cardiovascular Event
1 clinical trials · Condition
◉ Watch High Risk for Cardiovascular Event
| Record | Firm | Date |
|---|---|---|
| Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (NCT01730534) | AstraZeneca | 2013-04-25 |
Track High Risk for Cardiovascular Event automatically
Every clearance here is in the API, with alerts when new ones post.